Published on 29 Feb 2024 on Washington Post
Karyopharm Therapeutics: Q4 Earnings Snapshot
Start tracking your investments with Statfolio
Karyopharm Therapeutics Inc (KPTI) reports steady revenue growth and promising pipeline...
Karyopharm Therapeutics Inc (NASDAQ:KPTI) is set to release its Q3 2024 earnings on Nov 5, 2024. ...
On September 30, 2024, Highbridge Capital Management LLC made a significant move in the stock mar...
We recently compiled a list of the 10 Best One-Dollar Stocks To Buy Now. In this article, we are...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript May 8, 2024 Karyophar...
President and CEO Richard Paulson executed a sale of 99,844 shares of Karyopharm Therapeutics Inc...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript February 29, 2024 Kar...
Karyopharm Therapeutics (KPTI) came out with a quarterly loss of $0.36 per share versus the Zacks...
It is a pleasure to report that the Karyopharm Therapeutics Inc. (NASDAQ:KPTI) is up 139% in the ...